Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

TCR2 Therapeutics Inc. buy michaelkr

Start price
€1.89
02.10.22 / 50%
Target price
-
02.10.23
Performance (%)
-11.24%
End price
€1.68
16.10.22
Summary
This prediction ended on 16.10.22 with a price of €1.68. The price of TCR2 Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.24%. michaelkr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
TCR2 Therapeutics Inc. - - -
iShares Core DAX® 2.149% 5.415% 21.385%
iShares Nasdaq 100 0.838% 1.926% 44.386%
iShares Nikkei 225® 1.143% 2.887% 27.641%
iShares S&P 500 1.265% 3.698% 33.327%

According to michaelkr what are the pros and cons of TCR2 Therapeutics Inc. for the foreseeable future?

Pros
Cons
Risky Investment

Comments by michaelkr for this prediction

In the thread Tcr2 Therapeutics Inc. diskutieren

Buy TCR2 Therapeutics Inc.

In the thread Trading Tcr2 Therapeutics Inc.
Prediction Buy
Perf. (%) -11.24%
Target price
Change
Ends at 02.10.23

Buy beendet

Stopped prediction by michaelkr for TCR2 Therapeutics Inc.

buy
TCR2 Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.56
30.10.22
-
30.10.23
-16.12%
12.11.22

Risky Investment
buy
TCR2 Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.38
09.09.22
-
09.09.23
-6.96%
18.09.22

Risky Investment
buy
TCR2 Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.92
23.01.22
-
23.01.23
-7.53%
06.02.22

Risky Investment